Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1984 1
1988 1
1993 2
1994 2
1995 3
1998 2
2001 4
2009 2
2010 2
2011 2
2012 1
2013 4
2014 4
2015 5
2016 1
2017 1
2018 5
2019 6
2020 5
2021 6
2022 7
2023 3
2024 8
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Novel cancer therapy targeting microbiome.
Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y. Nagano T, et al. Among authors: otoshi t. Onco Targets Ther. 2019 May 13;12:3619-3624. doi: 10.2147/OTT.S207546. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190864 Free PMC article. Review.
Possible Biomarkers for Cancer Immunotherapy.
Otoshi T, Nagano T, Tachihara M, Nishimura Y. Otoshi T, et al. Cancers (Basel). 2019 Jul 3;11(7):935. doi: 10.3390/cancers11070935. Cancers (Basel). 2019. PMID: 31277279 Free PMC article. Review.
Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART).
Kato T, Nakano Y, Hongo F, Katano H, Miyagawa T, Ueda K, Azuma H, Nozawa M, Hinata N, Hori J, Otoshi T, Shimizu N, Aizawa M, Osada S, Matsui A, Oya M, Eto M, Tomita Y, Shinohara N, Uemura H. Kato T, et al. Among authors: otoshi t. Int J Urol. 2024 Mar;31(3):265-272. doi: 10.1111/iju.15345. Epub 2023 Dec 18. Int J Urol. 2024. PMID: 38110838 Free PMC article.
Irradiation plus myeloid-derived suppressor cell-targeted therapy for overcoming treatment resistance in immunologically cold urothelial carcinoma.
Yamamoto S, Kato M, Takeyama Y, Azuma Y, Yukimatsu N, Hirayama Y, Otoshi T, Yamasaki T, Fujioka M, Gi M, Wanibuchi H, Uchida J. Yamamoto S, et al. Among authors: otoshi t. Br J Cancer. 2023 Jun;128(12):2197-2205. doi: 10.1038/s41416-023-02244-8. Epub 2023 Apr 17. Br J Cancer. 2023. PMID: 37069346 Free PMC article.
Randomized cross-over trial of demand oxygen delivery system.
Nagano T, Kobayashi K, Omori T, Otoshi T, Umezawa K, Katsurada N, Yamamoto M, Tachihara M, Nishimura Y. Nagano T, et al. Among authors: otoshi t. Medicine (Baltimore). 2020 May;99(19):e20010. doi: 10.1097/MD.0000000000020010. Medicine (Baltimore). 2020. PMID: 32384457 Free PMC article.
74 results